Proteomics Market Size Worth over USD 94.7 Billion in 2035 | Roots Analysis

Pharmaceutical Contract Manufacturing Market Overview

The Pharmaceutical Contract Manufacturing Market is anticipated to be worth USD 100.3 billion in 2025 and this value is likely to reach over USD 155.4 billion by 2035, expanding at a CAGR of 4.5% between 2025 and 2035 according to a new report by Roots Analysis.

Pharmaceutical contract manufacturing organizations provide specialized services for the production of pharmaceutical products, allowing companies to outsource various stages of drug manufacturing and development to experts in the field. Outsourcing manufacturing operations to CMOs and CDMOs entails the implementation of specialized solutions to optimize production workflows, ensure regulatory compliance, and maintain product quality standards. Furthermore, there is a growing emphasis on personalized medicinal products, necessitating flexible manufacturing capabilities to meet diverse patient needs. This shift entails the essential role of CMOs and CDMOs in innovating production and meet the evolving healthcare demands.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/pharmaceutical-contract-manufacturing-market-2nd-edition-2018-2028/request-quote.html

Key Report Takeaways
1. The current market landscape features the presence of close to 510 players that claim to offer contract manufacturing services for pharmaceuticals across the world; 50% of these are headquartered in Asia-Pacific
2. Majority (~90%) of the pharmaceutical contract manufacturers offer services for producing finished dose formulations; further, >75% players offer services for fill finish / packaging and labeling
3. M&As allow companies to establish themselves as one-stop shops and build a competitive edge in the steadily evolving market landscape
4. In order to meet the rising demand for small molecules, CMOs have made significant investments in expanding their existing capacities and capabilities; in the recent past, this trend was most pronounced in Europe
5. The global pharmaceutical contract manufacturing capacity is well distributed across different facilities worldwide; notably, large and very large players account for more than 85% of the total capacity
6. In order to reduce high capital investments and operational costs associated with setting up and maintaining an in-house production facility, the demand for pharmaceutical contract manufacturing is anticipated to rise significantly
7. Owing to the enhanced cost efficiency and flexibility offered by CMOs, a relatively larger proportion of drug developers are outsourcing their manufacturing operations, driving the growth of this market
8. Currently, majority of the pharmaceutical contract manufacturing market share is captured by North America; this can be attributed to the advanced healthcare infrastructure, enabling players to conduct extensive research
9. The oral solids sub-segment is estimated to capture majority of the overall market share in the current year, owing to their cost-efficiency, ease of administration and high patient compliance

Competitive Landscape of Pharmaceutical Contract Manufacturers

The pharmaceutical contract manufacturing market is among the most promising domains in the healthcare industry. During our research, we were able to identify nearly 510 companies that are actively engaged in offering pharmaceutical contract manufacturing services. Notably, majority (~25%) of the players engaged in this domain were established pre-1970, signifying the presence of well-established players in the pharmaceutical contract manufacturing domain. Further, close to 15% players engaged in providing pharmaceutical contract manufacturing services have been established post-2010; examples of players established in 2024 include (in alphabetical order) EthixElite, Hycon and Merrals Overseas.

To request a sample copy / brochure of this report, please visit:
https://www.rootsanalysis.com/reports/pharmaceutical-contract-manufacturing-market-2nd-edition-2018-2028/request-sample.html

Pharmaceutical Contract Manufacturing Market Regional Outlook

Based on the geographical regions, the pharmaceutical contract manufacturing market can be segmented into three major regions, including North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa. Led by the US, North America is anticipated to capture the majority share of the pharmaceutical contract manufacturing market in 2025, and this trend is likely to remain unchanged during the forecast period. This can be attributed to well-established pharmaceutical contract manufacturing industry, along with robust infrastructure and significant investments in research and development of manufacturing technologies within this region.

Market Analysis: Low Potent APIs Dominate the Pharmaceutical Contract Manufacturing Market

In current year, low potent API hold 85% of the overall market share. This is primarily because of their suitability for bulk production and scalable processes. Further, pharmaceutical companies use these APIs for the treatment of various diseases, such as diabetes and infectious diseases. This widespread use drives consistently high global demand.

Pharmaceutical Contract Manufacturing Market Key Players
Examples of key companies engaged in pharmaceutical contract manufacturing market (which have also been profiled in this market report; the complete list of companies is available in the full report) include:

1. Albemarle
2. Aspen Pharmacare
3. Bausch Health Sciences
4. Catalent
5. Delpharm
6. Eurofins Scientific
7. Evonik Industries
8. Fareva
9. Fresenius Kabi
10. Intas Pharmaceuticals
11. Lonza
12. Micro Labs
13. Nipro Patch
14. Patheon
15. PiSA Farmacéutica
16. Recipharm
17. Sandoz
18. West Pharmaceutical Services
19. Wockhardt
20. WuXi AppTec

It is interesting to note that in August 2025, Aurobindo Pharma (India) completed the acquisition of Lannett (US) expanding the firm's global footprint to the US.

To get market data, market insights, financial statements and a comprehensive analysis of the Pharmaceutical Contract Manufacturing Market, please contact sales@rootsanalysis.com

Pharmaceutical Contract Manufacturing Market Segments

Based on the research, Roots Analysis has segmented the Pharmaceutical Contract Manufacturing Market into Type of Product Manufactured, Type of API, API Potency, Type of FDF, Dosage Form, Type of Oral Solid, Type of Packaging Offered, Scale of Operation, End User, Geographical Regions and Key Players.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/pharmaceutical-contract-manufacturing-market/191.html#overview

Pharmaceutical Contract Manufacturing Market, by Type of Product Manufactured
1. API and Intermediates
2. FDFs

Pharmaceutical Contract Manufacturing Market, by Type of API
1. Originator APIs
2. Generic APIs

Pharmaceutical Contract Manufacturing Market, by API Potency
1. Low Potent APIs
2. High Potent APIs

Pharmaceutical Contract Manufacturing Market, by Type of FDF
1. Originator FDFs
2. Generic FDFs

Pharmaceutical Contract Manufacturing Market, by Dosage Form
1. Oral Solids
2. Liquids
3. Emulsions
4. Other Dosage Forms

Pharmaceutical Contract Manufacturing Market, by Type of Oral Solid
1. Tablets
2. Capsules
3. Other Oral Solids

Pharmaceutical Contract Manufacturing Market, by Type of Packaging Offered
1. Bottles
2. Blister Packs
3. Oral Liquid Bottles
4. Vials
5. Prefilled Syringes
6. Cartridges
7. Ampoules
8. Other Types of Packaging

Pharmaceutical Contract Manufacturing Market, by Scale of Operation
1. Clinical Scale
2. Commercial Scale

Pharmaceutical Contract Manufacturing Market, by End User
1. Small Companies
2. Mid-sized Companies
3. Large and Very Large Companies

Pharmaceutical Contract Manufacturing Market, by Key Geographical Regions
1. North America
2. Europe
3. Asia-Pacific
4. Latin America
5. Middle East and North Arica

Don't miss out on other interesting titles
1. Biologics Contract Manufacturing Market (6th Edition), till 2035
2. Lipid Nanoparticle Manufacturing Market, till 2035
3. mRNA Synthesis and Manufacturing Market, till 2035
4. Cell Line Characterization and Cell Line Development Market, till 2035
5. Biologics Fill Finish Manufacturing Market (5th Edition), till 2035

Contact Details for Roots Analysis
Chief Executive: Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/

About Roots Analysis
Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.